BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months

Biotech catalysts in 2026-06

255 industry Phase 2/3 trial readout(s) and 40 FDA decision event(s). Readouts include completed (ACTUAL) and still-estimated primary completion dates in this month, any status.

← 2026-05 | 2026-07 →

FDA decision events

DateEventStatusCompanyDrugSource
2026-06-02FDA approvalapprovedCASPER PHARMA LLCTIOCYSTINApproved 2026-06-02: TIOCYSTIN (NDA212927 ORIG1)
2026-06-02FDA approvalapprovedLUPIN LIMITEDRANLUSPECApproved 2026-06-02: RANLUSPEC (BLA761480 ORIG1)
2026-06-04Complete response lettercomplete responseXspray Pharma AB(9) (nilotinib) capsulesCRL 2026-06-04: Xspray Pharma AB NDA 217644 ((9) (nilotinib) capsules)
2026-06-05FDA approvalapprovedPFIZER INC PFEHYMPAVZIApproved 2026-06-05: HYMPAVZI (BLA761369 SUPPL3)
2026-06-09FDA approvalapprovedELI LILLY AND CO LLYEBGLYSSApproved 2026-06-09: EBGLYSS (BLA761306 SUPPL6)
2026-06-10Complete response lettercomplete responseBridge Regulatory Affairs, LLCoctreotide hydrochloride extended- releaseCRL 2026-06-10: Bridge Regulatory Affairs, LLC NDA 218600 (octreotide hydrochloride extended- release injection)
2026-06-11FDA approvalapprovedHOFFMANN-LA ROCHEALECENSAApproved 2026-06-11: ALECENSA (NDA208434 SUPPL16)
2026-06-12FDA approvalapprovedPROVENTION BIO INCTZIELDApproved 2026-06-12: TZIELD (BLA761183 SUPPL10)
2026-06-12FDA approvalapprovedMERCK SHARP DOHME MRKWELIREGApproved 2026-06-12: WELIREG (NDA215383 SUPPL15)
2026-06-12FDA approvalapprovedMERCK SHARP DOHME MRKKEYTRUDAApproved 2026-06-12: KEYTRUDA (BLA125514 SUPPL192)
2026-06-12FDA approvalapprovedMERCK SHARP DOHME MRKKEYTRUDA QLEXApproved 2026-06-12: KEYTRUDA QLEX (BLA761467 SUPPL9)
2026-06-12FDA approvalapprovedBAYER HEALTHCAREAMBELVISTApproved 2026-06-12: AMBELVIST (NDA219627 ORIG1)
2026-06-12FDA approvalapprovedABBVIE INC ABBVSKYRIZIApproved 2026-06-12: SKYRIZI (BLA761105 SUPPL44)
2026-06-12FDA approvalapprovedASTRAZENECA AZNTRUQAPApproved 2026-06-12: TRUQAP (NDA218197 SUPPL4)
2026-06-15Complete response lettercomplete responseTris Pharma, Inc.oxybate for powder for suspensionCRL 2026-06-15: Tris Pharma, Inc. NDA 220138 (oxybate for extended-release powder for oral suspension (oxybate ER OS))
2026-06-16FDA approvalapprovedAZURITYAPREPITANTApproved 2026-06-16: APREPITANT (NDA218754 ORIG1)
2026-06-16FDA approvalapprovedAMPHASTAR PHARMS INC AMPHREXTOVYApproved 2026-06-16: REXTOVY (NDA208969 SUPPL2)
2026-06-17Complete response letterapproved sinceAvyxa Holdings, LLCCisplatinCRL 2026-06-17: Avyxa Holdings, LLC NDA 220748 (Cisplatin Injection)
2026-06-17FDA approvalapprovedGLAXOSMITHKLINEUTEBZIApproved 2026-06-17: UTEBZI (NDA215960 ORIG1)
2026-06-18FDA AdComheldAdCom 2026-06-18: Vaccines and Related Biological Products Advisory Committee
2026-06-18FDA approvalapprovedZEALAND PHARMA ZEAL.COZEGALOGUEApproved 2026-06-18: ZEGALOGUE; ZEGALOGUE (AUTOINJECTOR) (NDA214231 SUPPL4)
2026-06-20Complete response lettercomplete responseAchieve Life Sciences, Inc. QUITcytisiniclineCRL 2026-06-20: Achieve Life Sciences, Inc. NDA 218995 (cytisinicline tablet, ©)
2026-06-23Complete response lettercomplete responseTanvex BioPharma USA, Inc.CRL 2026-06-23: Tanvex BioPharma USA, Inc. BLA 761266
2026-06-24FDA approvalapprovedAVYXA HOLDINGSNAVITRUXApproved 2026-06-24: NAVITRUX (NDA220436 ORIG1)
2026-06-24FDA approvalapprovedPFIZER PFEIBRANCEApproved 2026-06-24: IBRANCE (NDA207103 SUPPL24)
2026-06-24FDA approvalapprovedMERCK SHARP DOHME MRKKEYTRUDAApproved 2026-06-24: KEYTRUDA (BLA125514 SUPPL187)
2026-06-24FDA approvalapprovedPFIZER PFEIBRANCEApproved 2026-06-24: IBRANCE (NDA212436 SUPPL12)
2026-06-24FDA approvalapprovedMERCK SHARP DOHME MRKKEYTRUDA QLEXApproved 2026-06-24: KEYTRUDA QLEX (BLA761467 SUPPL4)
2026-06-24FDA approvalapprovedIONIS PHARMS INC IONSTRYNGOLZAApproved 2026-06-24: TRYNGOLZA (AUTOINJECTOR) (NDA218614 SUPPL4)
2026-06-24FDA approvalapprovedIMMUNOMEDICS INCTRODELVYApproved 2026-06-24: TRODELVY (BLA761115 SUPPL64)
2026-06-24FDA approvalapprovedIMMUNOMEDICS INCTRODELVYApproved 2026-06-24: TRODELVY (BLA761115 SUPPL63)
2026-06-25FDA approvalapprovedMERZ PHARMSXeominApproved 2026-06-25: Xeomin (BLA125360 SUPPL108)
2026-06-26Complete response lettercomplete responseEvergreen Theragnostics, Inc.the Preparation of Gallium Ga EdotreotideCRL 2026-06-26: Evergreen Theragnostics, Inc. NDA 216900 (the Preparation of Gallium Ga Edotreotide Injection)
2026-06-26Complete response lettercomplete responseSwedish Orphan Biovitrum AB (publ)sirolimus for suspensionCRL 2026-06-26: Swedish Orphan Biovitrum AB (publ) BLA 761438 (sirolimus for injectable suspension)
2026-06-26FDA approvalapprovedDECIPHERA PHARMSROMVIMZAApproved 2026-06-26: ROMVIMZA (NDA219304 SUPPL2)
2026-06-26FDA approvalapprovedVIRIDIAN THERAPEUTICS INC VRDNLUMVOAApproved 2026-06-26: LUMVOA (BLA761530 ORIG1)
2026-06-26FDA approvalapprovedABBVIE INC ABBVSKYRIZIApproved 2026-06-26: SKYRIZI (BLA761105 SUPPL45)
2026-06-29Complete response lettercomplete responseUnicycive Therapeutics Inc. UNCYoxylanthanum carbonateCRL 2026-06-29: Unicycive Therapeutics Inc. NDA 218607 (oxylanthanum carbonate tablets)
2026-06-29Complete response lettercomplete responseIpsen Biopharm Ltd.relabotulinumtoxin ACRL 2026-06-29: Ipsen Biopharm Ltd. BLA 761311 (relabotulinumtoxin A injection)
2026-06-29FDA approvalapprovedARCUTIS ARQTZORYVEApproved 2026-06-29: ZORYVE (NDA215985 SUPPL15)

Trial readouts

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2026-06 est.P2Sound Pharmaceuticals, Incorporated SOGPNCT01451853 SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing LossLung Cancer; Head and Neck Cancer; Hearing Loss; Ototoxicity; Tinnitus; Neuropathywithdrawn
2026-06 est.P2Sound Pharmaceuticals, Incorporated SOGPNCT02779192 A Phase 2b Study of SPI-1005 to Prevent Acute Noise Induced Hearing LossNoise Induced Hearing Losswithdrawn
2026-06 est.P2Actuate Therapeutics Inc. ACTUNCT03678883 9-ING-41 in Patients With Advanced CancersCancer; Pancreatic Cancer; Sarcoma; Renal Cancer; Refractory Cancer; Refractory Neoplasm; Refractoryactive not recruiting350
2026-06 est.P3Cook MyoSiteNCT03997318 Japanese Bridging Study of Autologous Muscle Derived Cells Compared to Placebo for Female Urinary Sphincter Repair(JPN1)Stress Urinary Incontinencewithdrawn
2026-06 est.P2Pharmazz, Inc.NCT04054414 PMZ-1620 (Sovateltide) in Patients of Acute Spinal Cord InjuryAcute Spinal Cord Injuryrecruiting40
2026-06 est.P1/P2Rakuten Medical, Inc.NCT04305795 An Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid TumorsRecurrent Head and Neck Squamous Cell Carcinoma; Metastatic Head-and-neck Squamous-cell Carcinoma; Lactive not recruiting23
2026-06 est.P1/P24D Molecular Therapeutics FDMTNCT04517149 4D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP)X-Linked Retinitis Pigmentosaactive not recruiting21
2026-06 est.P2Y-mAbs TherapeuticsNCT04909515 Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GMCSF) and Isotretinoin for Consolidation of Patients With High-Risk Neuroblastoma in First RemiNeuroblastomawithdrawn
2026-06 est.P1/P2Verastem, Inc. VSTMNCT05074810 Phase 1/2 Study of Avutometinib (VS-6766) + Sotorasib With or Without Defactinib in KRAS G12C NSCLC PatientsNon Small Cell Lung Cancer; KRAS Activating Mutationactive not recruiting153
2026-06 est.P1/P2CG Pharmaceuticals, IncNCT05249101 A Study of Ivaltinostat Plus Capecitabine or Capecitabine in Metastatic Pancreatic AdenocarcinomaMetastatic Pancreatic Adenocarcinomaactive not recruiting70
2026-06 est.P2Clene Nanomedicine CLNNNCT05299658 An Open-Label Extension for the Phase 2 Study in Early Symptomatic Amyotrophic Lateral Sclerosis Patients on Stable Background Therapy to Assess Bioenergetic CaAmyotrophic Lateral Sclerosisactive not recruiting40
2026-06 est.P3Probelte Pharma S.L.U.NCT05395689 Efficacy and Safety Assessment of Beltavac® With Polymerized Extract of HDMHouse Dust Mite Allergyunknown350
2026-06 est.P1/P2Advanced BioDesignNCT05601726 First-in-human Study Aiming to Characterize the Safety, Tolerability, Pharmacokinetic and Preliminary Signs of Activity of ABD-3001 in Refractory or Relapsed AMAcute Myeloid Leukemia, Adult; Myelodysplastic Syndromesrecruiting36
2026-06 est.P1/P2InSightecNCT05615623 Blood Brain Barrier (BBB) Disruption Using Exablate Focused Ultrasound With Doxorubicin for Treatment of Pediatric DIPGBrain Tumoractive not recruiting10
2026-06 est.P1/P24D Molecular Therapeutics FDMTNCT05629559 4D-310 in Adults With Fabry Disease and Cardiac InvolvementFabry Diseaserecruiting18
2026-06 est.P1/P2InSightecNCT05630209 Blood Brain Barrier (BBB) Disruption Using Exablate Focused Ultrasound With Doxorubicin for Treatment of Pediatric Diffuse Intrinsic Pontine Gliomas (DIPG)Brain Tumoractive not recruiting10
2026-06 est.P2Vaneltix Pharma, Inc.NCT05737121 Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPSInterstitial Cystitis; Bladder Pain Syndromerecruiting120
2026-06 est.P1/P21ST Biotherapeutics, Inc.NCT05761223 A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849Advanced Solid Tumorrecruiting151
2026-06 est.P3RemeGen Co., Ltd.NCT05799287 A Study of Telitacicept for IgA Nephropathy (TELIGAN)Primary IgA Nephropathyactive not recruiting318
2026-06 est.P3RemeGen Co., Ltd.NCT05885503 Efficacy and Safety of RC28-E Versus Aflibercept in Diabetic Macular EdemaDiabetic Macular Edemaunknown316
2026-06 est.P1/P2Volastra Therapeutics, Inc.NCT05902988 A Phase I/II Study of VLS-1488 in Subjects With Advanced CancerAdvanced Solid Tumor; High Grade Serous Adenocarcinoma of Ovary; Squamous Non-small-cell Lung Cancerrecruiting200
2026-06 est.P2Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT05913089 A Clinical Study of TQB2450 Injection Combined With Chemotherapy or Anlotinib Hydrochloride Capsule in the Treatment of Non Small Cell Lung CancerNon Small Cell Lung Cancerrecruiting58
2026-06 est.P1/P2Juventas Cell Therapy Ltd.NCT06005649 Clinical Trial of HY004 Cell Injection in the Treatment of Relapsed or Refractory B-Cell Non-Hodgkin's LymphomaNon-hodgkin Lymphomawithdrawn
2026-06 est.P2Q32 Bio Inc. QTTBNCT06018428 A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)Alopecia Areataactive not recruiting75
2026-06 est.P2ITB-Med LLCNCT06019507 A Study of TCD601 in the Induction of Tolerance in de Novo Liver TransplantationLiver Transplantationactive not recruiting12
2026-06 est.P2Lakewood-Amedex Inc LABTNCT06020235 Nu-3 Gel for Infected Diabetic Foot UlcersDiabetic Foot Infectionnot yet recruiting60
2026-06 est.P1/P2COUR Pharmaceutical Development Company, Inc.NCT06106672 Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in Subjects With Myasthenia GravisMyasthenia Gravis; Generalized Myasthenia; AChR Myasthenia Gravis; MuSK MGactive not recruiting54
2026-06 est.P2/P3Sling Therapeutics, Inc.NCT06112340 Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)Thyroid Eye Disease; Graves Orbitopathy; Endocrine System Diseases; Eye Diseases; Thyroid Associatedrecruiting75
2026-06 est.P3Qilu Pharmaceutical Co., Ltd.NCT06151587 A Phase 3 Clinical Study of QLM3004 in Delaying Myopia in ChildrenMyopiarecruiting735
2026-06 est.P1/P2Shandong Suncadia Medicine Co., Ltd.NCT06167694 Clinical Study of HRS-8080 in Combination With Dalpiciclib Isethionate Tablets in Patients With Unresectable or Metastatic Breast CancerUnresectable or Metastatic Breast Cancerrecruiting146
2026-06 est.P2RemeGen Co., Ltd.NCT06178159 DV in Combination With Pertuzumab With or Without Toripalimab Neoadjuvant Therapy With HER2-positive Breast CancerBreast Cancerrecruiting40
2026-06 est.P3EMSNCT06264414 Efficacy and Safety of the DTT106 in the Treatment of Erectile Dysfunction Associated With Benign Prostatic HyperplasiaProstatic Hyperplasia, Benign; Erectile Dysfunctionnot yet recruiting262
2026-06 est.P2Noema Pharma AGNCT06315751 Efficacy and Safety of Gemlapodect (NOE-105) in Adults and Adolescents With Tourette SyndromeTourette Syndromeactive not recruiting164
2026-06 est.P2Philogen S.p.A.NCT06336291 A Study With L19TNF in Combination With Lomustine in Patients With Glioblastoma at Progression or RecurrenceGlioblastomaactive not recruiting90
2026-06 est.P2BioMarin Pharmaceutical BMRNNCT06382155 A Phase 2 Study of Vosoritide in Children With Idiopathic Short StatureIdiopathic Short Staturerecruiting100
2026-06 est.P1/P2GRIN Therapeutics, Inc.NCT06392009 Astroscape: A Study of Radiprodil on Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms in Patients With TSC or FCD Type IITuberous Sclerosis Complex; Focal Cortical Dysplasiaactive not recruiting30
2026-06 est.P2Vaneltix Pharma, Inc.NCT06394830 Safety, Efficacy, and Frequency of Administration of VNX001 in the Treatment of Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS)Interstitial Cystitis; Bladder Pain Syndromerecruiting50
2026-06 est.P3Jiangsu HengRui Medicine Co., Ltd.NCT06414837 Clinical Trial of HR091506 Tablets in Treatment of Gout With Hyperuricemia in AdultsGout With Hyperuricemia in Adultsunknown434
2026-06 est.P2AlaMab Therapeutics (Shanghai) Inc.NCT06416358 A Study to Evaluate the Efficacy of ALMB-0168 in Solid Tumor Patients With Bone Metastatic Whose Prior Standard Treatment Have FailedAdvanced Solid Tumors With Bone Only Metastasisnot yet recruiting144
2026-06 est.P2Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.NCT06452706 The Clinical Trial of TQB2102 for Injection Against Human Epidermal Growth Factor Receptor 2 Negative Breast CancerBreast Cancerrecruiting42
2026-06 est.P2Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.NCT06496490 A Clinical Trial of TQB2102 for Injection in Non-small Cell Lung Cancer With HER2 Gene AbnormalityNon-Small Cell Lung Cancerrecruiting270
2026-06 est.P2Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT06500091 TQB2916 Injection Combined With Chemotherapy or Penpulimab Injection in the Treatment of Solid TumorsSoft Tissue Sarcoma; Melanomanot yet recruiting54
2026-06 est.P1/P2AkesoNCT06530251 A Study of AK112 in Patients With Advanced Hepatocellular Carcinoma (HCC)Hepatocellular Carcinomarecruiting280
2026-06 est.P3Chengdu Kanghong Pharmaceutical Group Co., Ltd.NCT06589817 A Double-Blind, Randomized Comparative Study of Carliprazine and Aripiprazole in Patients with Acute SchizophreniaAcute Schizophrenianot yet recruiting376
2026-06 est.P3Revolution Medicines, Inc. RVMDNCT06625320 Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)Pancreatic Cancer; PDAC; PDAC - Pancreatic Ductal Adenocarcinomaactive not recruiting500
2026-06 est.P2Autobahn Therapeutics, Inc.NCT06633016 Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)Major Depressive Disorderrecruiting230
2026-06 est.P3BiocadNCT06640517 Study of the Efficacy, Safety, Pharmacokinetics, and Immunogenicity of Netakimab in Children With Moderate to Severe Plaque PsoriasisPlaque Psoriasisactive not recruiting140
2026-06 est.P3Santen Pharmaceutical Co., Ltd.NCT06683651 A Study in Chinese Patients With Acquired BlepharoptosisBlepharoptosisrecruiting180
2026-06 est.P3Sagimet Biosciences Inc. SGMTNCT06692283 A Phase 3 Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASLD and MASHMASLD; MASH; NASH; Metabolic Dysfunction-Associated Steatotic Liver Disease; Metabolic Dysfunction-Awithdrawn
2026-06 est.P2Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT06702618 Evaluation of TQB3616 Capsules in a Phase II Clinical Trial for Recurrent/Metastatic Breast CancerBreast Canceractive not recruiting33
2026-06 est.P2Qilu Pharmaceutical Co., Ltd.NCT06750341 Study of QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated LDL CholesterolPrimary Hypercholesterolemia or Mixed Hyperlipidemianot yet recruiting156
2026-06 est.P2Mabwell (Shanghai) Bioscience Co., Ltd.NCT06823427 9MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial CarcinomaUrothelial Carcinoma; Urothelial Carcinoma Bladder; Urothelial Carcinoma Recurrent; Urothelial Carcirecruiting60
2026-06-01P3AstraZeneca AZNNCT03682068 Study of Durvalumab Given With Chemotherapy, Durvalumab in Combination With Tremelimumab Given With Chemotherapy, or Chemotherapy in Patients With Unresectable Unresectable Locally Advanced Urothelial Cancer; Metastatic Urothelial Canceractive not recruiting1246
2026-06-01 est.P1/P2Intralytix, Inc.NCT03808103 Safety and Efficacy of EcoActive on Intestinal Adherent Invasive E. Coli in Patients With Inactive Crohn's DiseaseCrohn Diseaseactive not recruiting30
2026-06-01 est.P1/P2BioIntegrateNCT04711304 Evaluation of Safety and Efficacy of Wharton's Jelly Compared to Hyaluronic Acid and Saline for Knee Osteoarthritis.Osteoarthritis, Kneeunknown168
2026-06-01 est.P1/P2Alligator Bioscience ABNCT04888312 Safety and Efficacy of Mitazalimab in Combination With Chemotherapy in Pancreatic Cancer PatientsMetastatic Pancreatic Ductal Adenocarcinomaactive not recruiting94
2026-06-01 est.P3Laboratorio Elea Phoenix S.A.NCT04897516 Shorter Benznidazole Regimens Compared to the Standard Regimen for Chagas DiseaseChagas Diseaserecruiting300
2026-06-01 est.P2/P3Jiangsu HengRui Medicine Co., Ltd.NCT05442827 A Phase II/III Study of Efficacy and Safety of SHR7280 Tablets in Subjects With Menorrhagia With Uterine FibroidsUterine Fibroids With Menorrhagiaunknown357
2026-06-01 est.P1/P2Gylden Pharma LtdNCT05633446 Next Generation T-cell Vaccine Against Coronavirus Disease (COVID-19)Coronavirus; SARS-CoV-2 Infection; COVID-19not yet recruiting110
2026-06-01 est.P2/P3Inmunotek S.L.NCT05641272 Clinical Trial to Evaluate the Efficacy and Safety of Polymerized, Mannan-Conjugated Dermatophagoides Allergen ExtractAllergic Rhinitis; Allergic Asthma; Allergic Rhinoconjunctivitis; Allergy to House Dust Mitenot yet recruiting90
2026-06-01 est.P1/P2ViiV HealthcareNCT05674656 Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in PediatricsHIV Infectionsrecruiting20
2026-06-01P3IpsenNCT06047457 A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in AdultsEpisodic Migraineactive not recruiting751
2026-06-01P3Boehringer IngelheimNCT06077864 A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)Obesitycompleted5530
2026-06-01 est.P2/P3Oncotelic Inc. OTLCNCT06079346 A Study of OT-101 With mFOLFIRINOX in Patients With Advanced and Unresectable or Metastatic Pancreatic CancerPancreatic Ductal Adenocarcinomarecruiting455
2026-06-01 est.P3CSPC ZhongQi Pharmaceutical Technology Co., Ltd.NCT06296706 A Clinical Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric CancerGastric Cancerrecruiting630
2026-06-01P3Arrowhead Pharmaceuticals ARWRNCT06347133 Phase 3 Study of Plozasiran in Adults With HypertriglyceridemiaHypertriglyceridemiacompleted1456
2026-06-01 est.P2/P3Hansoh BioMedical R&D CompanyNCT06417008 A Study of HS-20117 Combined With Aumolertinib in Participants With Advanced Non-Squamous Non-Small Cell Lung CancerNon-Squamous Non-Small Cell Lung Cancerrecruiting1080
2026-06-01 est.P2Arcturus Therapeutics, Inc. ARCTNCT06488313 A Study to Evaluate the Pharmacodynamics and Safety of ARCT-810 in Participants With OTCDOTC Deficiency; Ornithine Transcarbamylase Deficiency; OTCDrecruiting9
2026-06-01P1/P2Dimagi Inc.NCT06845878 A Chatbot To Support Substance Use RecoveryOpiate-Related Disorders; Opiate Substitution Treatmentcompleted55
2026-06-01 est.P2/P3SFA TherapeuticsNCT06863493 Comparison of Otezla to SFA-002 to Placebo in Plaque Psoriasis PatientsPsoriasis (PsO)not yet recruiting125
2026-06-01 est.P1/P2CASI pharmaceuticals, Inc. CASIFNCT07017725 A Dose-escalation Study Followed by a Dose Optimal Study to Evaluate the Safety and Efficacy of CID-103 in Adults With Chronic Immune ThrombocytopeniaChronic Immune Thrombocytopeniarecruiting75
2026-06-01 est.P1/P2Eluciderm IncNCT07396376 Evaluation of ELU42 Topical Spray for the Treatment of Diabetic Foot UlcersDiabetic Foot Ulcer; Wagner Grade 1 - 2; Chronic Wound; Open Woundrecruiting15
2026-06-01 est.P3Oils4CureNCT07403266 Treatment With Full-spectrum Cannabis Extract of Refractory Epilepsy Associated With Tuberous Sclerosis Complex (TSC)Tuberous Sclerosis Complex (TSC)recruiting84
2026-06-01P3Colgate Palmolive CLNCT07442136 Clinical Study to Assess the Efficacy of New Toothpaste Containing SnF as Compared to Colgate Cavity Protection Toothpaste on the Reduction of Enamel ErosionEnamel Erosioncompleted80
2026-06-01 est.P2Intra-IMMUSG Pte LtdNCT07541001 PRL3-Zumab in Patients With Advanced Solid TumorsAdvanced Malignant Solid Tumoractive not recruiting60
2026-06-02P1/P2Binhui Biopharmaceutical Co., Ltd.NCT04386967 OH2 Injection in Solid TumorsSolid Tumor; Melanomacompleted44
2026-06-02P3Swedish Orphan BiovitrumNCT05817812 A Study Evaluating Physical Activity and Joint Health in Severe Haemophilia A Patients ≥12 Years Treated Once Weekly With Efanesoctocog AlfaHemophilia A, Severecompleted93
2026-06-02P1/P2Sensei Biotherapeutics, Inc.NCT05864144 A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid TumorsSolid Tumor, Adult; Advanced Solid Tumor; Head and Neck Cancer; Breast Cancer; Colon Cancer; Pancreacompleted98
2026-06-02P3Eli Lilly and Company LLYNCT06075667 A Study of Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity or Overweight With Weight-Related ComorbiditiesObesity; Overweightactive not recruiting160
2026-06-02P3Novo Nordisk A/S NVONCT06534411 A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLDiabetes Mellitus, Type 2completed1023
2026-06-03P3Hoffmann-La RocheNCT04712097 A Study Evaluating the Efficacy and Safety of Mosunetuzumab in Combination With Lenalidomide in Comparison to Rituximab in Combination With Lenalidomide With a Relapsed or Refractory Follicular Lymphomaactive not recruiting478
2026-06-03P2Kyowa Kirin Co., Ltd.NCT06116890 Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular DegenerationNeovascular Age-Related Macular Degeneration (nAMD)completed170
2026-06-03 est.P1/P2Ikaria Bioscience Pty LtdNCT06471543 Study of RN0361in Adult Healthy Subjects and Adult Hypertriglyceridemic SubjectsHypertriglyceridemia; Familial Chylomicronemia Syndromeactive not recruiting108
2026-06-04P2MapLight Therapeutics MPLTNCT07038876 A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Inpatient Adults With SchizophreniaSchizophreniacompleted307
2026-06-04P2Fulcrum Therapeutics FULCNCT07401823 Open-Label Extension Study to Pioneer Study 6058-SCD-101Sickle Cell Diseaseterminated1
2026-06-05P3Suzhou Suncadia Biopharmaceuticals Co., Ltd.NCT06640257 A Study of the Efficacy and Safety of SHR-1314 for Adult Active Psoriatic ArthritisPsoriatic Arthritisactive not recruiting208
2026-06-05P2Merck Sharp & Dohme LLC MRKNCT06721156 A Study to Evaluate the Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia (MK-1167-008)Alzheimer Disease; Dementiaterminated369
2026-06-05 est.P2Haisco Pharmaceutical Group Co., Ltd.NCT06902428 Evaluating the Efficacy and Safety of of HSK44459 in Patients With Behçet's DiseaseBehcet's Diseasenot yet recruiting120
2026-06-05P3Merz North America, Inc.NCT07122193 A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in the United StatesNeuromuscular Agents; Peripheral Nervous System Agents; Physiological Effects of Drugs; Acetylcholinactive not recruiting300
2026-06-06P3Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd.NCT07080931 Efficacy and Safety of 5% Minoxidil Foam in Female Androgenetic AlopeciaAndrogenetic Alopeciacompleted296
2026-06-06P3Colgate Palmolive CLNCT07471477 Bacterial Reduction for a Manual Toothbrush With a 360-Degree Mouth Cleaner Design Versus a Standard ToothbrushBacterial Load Reductioncompleted56
2026-06-07 est.P3Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.NCT06945107 A Study of Switching to Picankibart in Chinese Patients With Plaque Psoriasis With an Inadequate Response to Interleukin-17 Monoclonal Antibody TherapyPlaque Psoriasisactive not recruiting308
2026-06-07 est.P2Shanghai Argo Biopharmaceutical Co., Ltd.NCT07135349 A Phase II Clinical Study of BW-20507 in Combination With PEG-IFNα for the Treatment of Hepatitis BChronic Hepatitis Bactive not recruiting209
2026-06-08P2Merck Sharp & Dohme LLC MRKNCT04123366 Study of Olaparib (MK-7339) in Combination With Pembrolizumab (MK-3475) in the Treatment of Homologous Recombination Repair Mutation (HRRm) and/or Homologous ReSolid Tumorscompleted333
2026-06-08P2Dizal PharmaceuticalsNCT06295432 A Phase II Clinical Trial of DZD9008 in Combination With AZD4205 in Standard Treatment Failed NSCLC Patients With EGFR Mutations (WU-KONG21)Non-small Cell Lung Cancercompleted30
2026-06-08 est.P2Regeneron Pharmaceuticals REGNNCT06384820 Study of Cemiplimab Alone or in Combination With Fianlimab and/or Other Experimental Agents in Adult Participants With Peri-operative Stage III/IV Cutaneous SquCutaneous Squamous Cell Carcinomawithdrawn
2026-06-08P3Sanofi SNYNCT06687967 A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged Lichen Simplex Chronicuscompleted142
2026-06-08P3Sanofi SNYNCT06687980 A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged Lichen Simplex Chronicuscompleted138
2026-06-08P1/P2Nanjing Immunophage Biotech Co., LtdNCT06717815 Phase IIa Study for IPG11406 in Patients With Lupus NephritisLupus Nephritiscompleted24
2026-06-09P3Novo Nordisk A/S NVONCT05021835 ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and InflammationCardiovascular Risk; Chronic Kidney Disease; Inflammationcompleted6385
2026-06-09P3AstraZeneca AZNNCT05048797 A Study to Investigate the Efficacy and Safety of Trastuzumab Deruxtecan as the First Treatment Option for Unresectable, Locally Advanced/Metastatic Non-Small CLocally Advanced or Metastatic Non-Small Cell Lung Canceractive not recruiting454
2026-06-09 est.P2Novartis Pharmaceuticals NVSNCT05750628 Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plasmodium Falciparum MalariaUncomplicated Plasmodium Falciparum Malariarecruiting327
2026-06-09P3Endo USA Inc., a Keenova Therapeutics CompanyNCT06151197 Study to Assess EN3835 in the Treatment of Plantar Fibromatosis (Also Known as Ledderhose Disease)Plantar Fibromatosis; Ledderhose Diseasecompleted436
2026-06-10P1/P2Novartis Pharmaceuticals NVSNCT03945318 Safety and Tolerability of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy (IgAN)IgA Nephropathycompleted103
2026-06-10P3SK Life Science, Inc.NCT03961568 Cenobamate Open-Label Extension Study for YKP3089C025Primary Generalized Tonic Clonic Seizures in the Setting of Idiopathic Generalized Epilepsycompleted147
2026-06-10P3Bellus Health Inc. - a GSK companyNCT05600777 A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic CoughCough; Refractory Chronic Coughactive not recruiting997
2026-06-10P2Genmab GMABNCT05660967 Subcutaneous Epcoritamab With or Without Lenalidomide as First Line Therapy for Diffuse Large B-Cell LymphomaDiffuse Large B-Cell Lymphomaterminated111
2026-06-10P2/P3TWi Biotechnology, Inc.NCT06073132 An International, Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled, Phase 2/3 Study With Open-Label Extension Evaluating the Efficacy aGeneralized Epidermolysis Bullosa Simplexactive not recruiting80
2026-06-10P3Sanofi SNYNCT06290128 A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Chronic Inflammatory Demyelinating Polyradiculoneuropathy; Polyneuropathy, Inflammatory Demyelinatinactive not recruiting109
2026-06-10P3Sanofi SNYNCT06407934 A Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Compared With Treatment Withdrawal in Participants Aged 1Dermatitis Atopicactive not recruiting1541
2026-06-10P2Dizal PharmaceuticalsNCT06539195 DZD8586 in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (TAI-SHAN9)Diffuse Large B Cell Lymphomacompleted59
2026-06-10P3Kedrion S.p.A.NCT06963216 A Study Investigating Coagadex in the Treatment AFXD Associated With AL AmyloidosisAcquired Factor X Deficiencywithdrawn
2026-06-11P3Cook MyoSiteNCT03104517 Autologous Muscle Derived Cells Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress IncontinenceStress Urinary Incontinenceactive not recruiting96
2026-06-11P3HTA Co., Ltd.NCT06754085 Study of 18F-Florastamin PET/CT Imaging in Patients With Suspected Recurrence of Prostate CancerProstate Cancercompleted131
2026-06-12P2Beeline Medicines Corporation BLNENCT04895696 A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)Systemic Lupus Erythematosusactive not recruiting248
2026-06-12P3Arrowhead Pharmaceuticals ARWRNCT06347003 Study of Plozasiran (ARO-APOC3) in Adults With Severe HypertriglyceridemiaSevere Hypertriglyceridemiacompleted446
2026-06-12P3Genrix (Shanghai) Biopharmaceutical Co., Ltd.NCT06516302 A Study of GR1802 in Participants With Chronic Sinusitis With Nasal PolypsChronic Rhinosinusitis With Nasal Polypscompleted228
2026-06-12P2Ono Pharmaceutical Co., Ltd.NCT06752603 A Clinical Study of ONO-1110 in Patients With Hunner Type Interstitial CystitisHunner Type Interstitial Cystitiscompleted57
2026-06-12P2VistaGen Therapeutics, Inc. VTGNNCT06809179 A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With SSocial Anxiety Disordercompleted61
2026-06-12 est.P2/P3Nasus Pharma NSRXNCT07045701 FMXIN002 in Patients at Risk of AnaphylaxisAnaphylaxis Foodenrolling by invitation30
2026-06-12P2Shaanxi Micot Pharmaceutical Technology Co., Ltd.NCT07205328 A Clinical Trial of MT200605 for the Treatment of Acute Ischemic StrokeAcute Ischemic Strokecompleted360
2026-06-12P3TLC Biopharmaceuticals, Inc.NCT07222748 A Study of TLC590 for Postsurgical Pain Following BunionectomyPostoperative Painactive not recruiting304
2026-06-14P2Reconnect LabsNCT06685965 A Study to Evaluate Effects on Sleep and Safety of RE03 in PTSD Patients With Sleep DisturbancesPosttraumatic Stress Disorder (PTSD); Sleep Disturbances and Insomniacompleted12
2026-06-15P3Merck Sharp & Dohme LLC MRKNCT05298423 Study of Pembrolizumab/Vibostolimab (MK-7684A) in Combination With Concurrent Chemoradiotherapy Followed by Pembrolizumab/Vibostolimab Versus Concurrent ChemoraCarcinoma, Non-Small-Cell Lungcompleted610
2026-06-15P1/P2Verastem, Inc. VSTMNCT05375994 Study of Avutometinib (VS-6766) + Adagrasib in KRAS G12C NSCLC PatientsNon Small Cell Lung Cancer; KRAS Activating Mutation; Advanced Cancer; Metastatic Cancer; Malignant completed12
2026-06-15P1/P2T-ACE Medical Co., LtdNCT05435014 T-ACE Oil by TAE/TACE in Patients With Hepatocellular CarcinomaHepatocellular Carcinomaterminated2
2026-06-15 est.P2Jiangsu HengRui Medicine Co., Ltd.NCT05896020 A Study of SHR-A1811 in Subjects With Gynaecologic OncologyGynaecological Malignanciesunknown225
2026-06-15P2ShionogiNCT05953480 A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic StrokeAcute Ischemic Strokecompleted680
2026-06-15 est.P2/P3Suzhou Suncadia Biopharmaceuticals Co., Ltd.NCT06211023 A Study of SHR-A1921 With or Without Carboplatin in Subjects With Ovarian CancerOvarian Cancerunknown520
2026-06-15 est.P2Nocion TherapeuticsNCT06504446 Study to Assess the Efficacy, Safety, and Tolerability of NOC-110 in Adults With Refractory or Unexplained Chronic CoughRefractory or Unexplained Chronic Coughactive not recruiting455
2026-06-15 est.P2Wuhan Createrna Science and Technology Co., LtdNCT06687174 Study to Evaluate the Efficacy and Safety of MY008211A in Subjects with Primary Immunoglobulin a Nephropathy (IgAN)IgA Nephropathy (IgAN)not yet recruiting72
2026-06-15P2CyanVac LLCNCT06742281 A Phase 2b, Randomized, Double-blind, Active-controlled Study of Single Dose CVXGA Intranasal COVID-19 Vaccine in AdultsCOVID-19completed432
2026-06-15 est.P3Guangdong Raynovent Biotech Co., LtdNCT06893016 Evaluation of RAY1225 in Adult Participants Who Have Obesity or Are OverweightObesityrecruiting640
2026-06-15 est.P2Sinovac Life Sciences Co., Ltd.NCT06967272 PhaseⅡClinical Trial of Oral Hexavalent Reassortant Rotavirus Attenuated Live Vaccine (Vero Cells)Rotavirus Gastroenteritisrecruiting400
2026-06-15 est.P2Aspargo Labs, IncNCT07290400 Effect of Moderate Alcohol on Absorption and Onset of Hezkue Sildenafil SuspensionErectile Dysfunctionnot yet recruiting36
2026-06-16P2Hanmi Pharmaceutical Company Limited HAFCNCT04732416 HM15136 (Efpegerglucagon) Treatment for 8 Weeks in Subjects Aged ≥2 Years With Congenital Hyperinsulinism (CHI)Congenital Hyperinsulinismactive not recruiting17
2026-06-16P3Exelixis EXELNCT05425940 Study of XL092 + Atezolizumab vs Regorafenib in Participants With Metastatic Colorectal CancerColorectal Canceractive not recruiting901
2026-06-16 est.P2Guangdong Raynovent Biotech Co., LtdNCT05692492 A Randomized, Double-blind, Placebo-controlled Study of ZSP1601 in Adult Subjects With Nonalcoholic Steatohepatitis (NASH)Nonalcoholic Steatohepatitis (NASH)active not recruiting180
2026-06-16P3Eli Lilly and Company LLYNCT05929079 A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or OverweightType 2 Diabetes; Obesity; Overweight; Obstructive Sleep Apneacompleted1152
2026-06-16P2Regeneron Pharmaceuticals REGNNCT06299098 A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for WeigObesitycompleted1005
2026-06-16P3IpsenNCT06383403 A Study of Elafibranor in Adults With Primary Biliary Cholangitis and Inadequate Response or Intolerance to Ursodeoxycholic Acid.Primary Biliary Cholangitiscompleted92
2026-06-16P1/P2Kyverna Therapeutics KYTXNCT06400303 KYSA-5: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Systemic SclerosisSystemic Sclerosis; Systemic Sclerosis - Diffuse Cutaneous; Systemic Sclerosis - 2013 ACR/EULAR Clasterminated3
2026-06-17P1/P2Precision Biologics, Inc DTILNCT03476681 Study of NEO-201 in Solid Tumors Expansion CohortsNon Small Cell Lung Cancer; Head and Neck Squamous Cell Carcinoma; Cervical Cancer; Uterine Canceractive not recruiting121
2026-06-17P2Regeneron Pharmaceuticals REGNNCT03888105 A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previously Treated With OtB-cell Non-Hodgkin Lymphoma (B-NHL)active not recruiting515
2026-06-17P3Ionis Pharmaceuticals, Inc. IONSNCT04768972 FUSION: A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ION363 in Amyotrophic Lateral Sclerosis Participants With Fused in SaAmyotrophic Lateral Sclerosisactive not recruiting89
2026-06-17P3Arrowhead Pharmaceuticals ARWRNCT06347016 Study of Plozasiran in Adults With Severe HypertriglyceridemiaSevere Hypertriglyceridemiacompleted311
2026-06-17P2SoLa Pelvic TherapyNCT06673108 Vaginal Photobiomodulation for Chronic Pelvic PainChronic Pelvic Pain; Chronic Pelvic Pain Syndrome (CPPS)completed128
2026-06-17P3BayerNCT06904274 Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 MonthsEndometrial Hyperplasiawithdrawn
2026-06-17P3Hansoh BioMedical R&D CompanyNCT06935409 Study of HS-20093 Versus Gemcitabine in Combination With Docetaxel in Treatment of Osteosarcoma After Previous Second-line Treatment FailureOsteosarcomacompleted122
2026-06-17P1/P2Capsida Biotherapeutics, Inc.NCT07011771 A Clinical Trial of CAP-003 Gene Therapy in Adult Patients With GBA1 Associated Parkinson's DiseaseGBA1 Parkinson Diseasewithdrawn
2026-06-17P3Shanghai Shengdi Pharmaceutical Co., LtdNCT07275814 A Study of a Gadolinium-Based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Central Nervous System For Contrast-enhanced Magnetic Resonance Imaging (MRI) of Central Nervous System (CNS) Lesionscompleted250
2026-06-17P2Novartis Pharmaceuticals NVSNCT07811882 Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria (Cohort B1)Uncomplicated Plasmodium Falciparum Malariacompleted95
2026-06-18P2AbbVie ABBVNCT04567550 RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Diabetic Retinopathy (DR) With and Without Center Involved-Diabetic Macular Diabetic Retinopathy (DR); Center-Involved Diabetic Macular Edema (CI-DME)completed139
2026-06-18P3Taiho Pharmaceutical Co., Ltd.NCT04587908 A Phase 3 Study of TAS-205 in Patients With Duchenne Muscular Dystrophy(REACH-DMD)Duchenne Muscular Dystrophycompleted104
2026-06-18P3Atea Pharmaceuticals, Inc. AVIRNCT06868264 C-BEYOND: Efficacy and Safety of BEM/RZR vs. SOF/VEL in Subjects With Chronic HCVHEPATITIS C VIRUS CHRONIC INFECTIONcompleted940
2026-06-18P2Zhejiang Doer Biologics Co., Ltd.NCT07024212 Phase II Study Evaluating the Efficacy and Safety of DR10624 Injection in MASLD and MetALD SubjectsMASLDactive not recruiting110
2026-06-19P3AbbVie ABBVNCT03891446 Long-term Safety and Efficacy Extension Trial of Bimatoprost SROpen-Angle Glaucoma; Ocular Hypertensioncompleted455
2026-06-19P1/P2Passage Bio, Inc. PASGNCT04747431 A Study of PBFT02 in Participants With FTD and Mutations in the Granulin Precursor (GRN) or C9ORF72 GenesFrontotemporal Dementia; FTD; FTD-GRN; Dementia Frontotemporal; C9orf72terminated30
2026-06-19P2Pfizer PFENCT05217446 A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic ColorectaMetastatic Colorectal Canceractive not recruiting108
2026-06-19P2CelgeneNCT06425302 A Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular LymphomaLymphoma, Follicularactive not recruiting95
2026-06-20 est.P1/P2CSPC ZhongQi Pharmaceutical Technology Co., Ltd.NCT05055791 A Study to Evaluate the Safety and Tolerance of SYHX1903 in Patients With Relapsed/Refractory Hematologic MalignanciesAcute Myeloid Leukemia; Lymphoma; Multiple Myelomaunknown312
2026-06-20P2Agomab Spain S.L.U.NCT05843578 STENOVA - A Study to Evaluate Safety, Tolerability, PK and PD of AGMB-129 in Patients With Fibrostenotic Crohn's DiseaseFibrostenotic Crohn's Diseasecompleted103
2026-06-20 est.P3Alebund PharmaceuticalsNCT06933472 A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and ChinaHyperphosphatemia; Chronic Kidney Disease, Receiving Dialysis; ESRD (End-Stage Renal Disease); Dialyrecruiting264
2026-06-22 est.P2Cellectar Biosciences, Inc. CLRBNCT02952508 Study of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in WaldenstromWaldenstrom Macroglobulinemia; Multiple Myeloma; Chronic Lymphocytic Leukemia; Small Lymphocytic Lymactive not recruiting120
2026-06-22P3Albireo, an Ipsen CompanyNCT04336722 Efficacy and Safety of Odevixibat in Children With Biliary Atresia Who Have Undergone a Kasai HPE (BOLD)Biliary Atresiacompleted254
2026-06-22 est.P2/P3Alexion Pharmaceuticals, Inc.NCT05346354 Efficacy and Safety Study of Ravulizumab IV in Pediatric Participants With NMOSDNeuromyelitis Optica Spectrum Disorderactive not recruiting12
2026-06-22P2Biocomposites LtdNCT05539963 A Feasibility Trial to Investigate the Safety and Between-group Effect Size of STIMULAN VG and Standard of Care (SoC) in Participants With Diabetic Foot OsteomyDiabetic Foot Osteomyelitiscompleted61
2026-06-22P1/P2Anaveon AGNCT06470763 A Study Evaluating ANV600 Single Agent or in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (EXPAND-1)Advanced Solid Tumorcompleted63
2026-06-22 est.P1/P2GlaxoSmithKlineNCT06710847 A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Effectiveness of GSK4418959 Alone or in Combination With Other Anti-cancer Agents in ParticNeoplasms, Colorectal; Solid Tumor; Colon Cancer; Rectal Cancer; Endometrial Canceractive not recruiting14
2026-06-22P2Beijing Continent Pharmaceutical Co, Ltd.NCT07364448 A Study to Evaluate the Safety of Hydronidone Capsules in Patients With Liver FibrosisChronic Hepatitis B With Hepatic Fibrosiscompleted411
2026-06-22P2/P3Amphastar Pharmaceuticals, Inc. AMPHNCT07560150 Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar/Interchangeable Rapid-Acting Insulin Aspart (I004) and NoPharmacokinetics; Pharmacodynamics; Insulin Aspartcompleted62
2026-06-23P1/P2Mirati Therapeutics Inc.NCT03785249 Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1Advanced Cancer; Metastatic Cancer; Malignant Neoplastic Diseaseactive not recruiting731
2026-06-23P2Alumis Inc ALMSNCT05966480 Phase 2 Placebo-Controlled Study to Assess the Safety and Efficacy of ESK-001 in Active Systemic Lupus ErythematosusSLEactive not recruiting408
2026-06-23P2Pharming Technologies B.V. PHARNCT06549114 Leniolisib for Immune Dysregulation in PIDsPrimary Immunodeficiency Disorders (PIDs)completed13
2026-06-23P2Novartis Pharmaceuticals NVSNCT06643481 A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS)Amyotrophic Lateral Sclerosis (ALS)active not recruiting251
2026-06-24P3Diamyd Medical ABNCT05018585 A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 DType 1 Diabetes Mellitusterminated321
2026-06-24P2Debiopharm International SANCT06395753 A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate CancerProstate Cancercompleted55
2026-06-24P3Rhythm Pharmaceuticals, Inc. RYTMNCT06596135 Open-Label Extension Study of SetmelanotideObesity Associated With Defects in Leptin-melanocortin Pathwaycompleted28
2026-06-24 est.P1/P2Sinocelltech Ltd.NCT06769984 A Study of SCTT11 in Healthy Participants and Participants with Thyroid Eye Disease.TEDnot yet recruiting100
2026-06-24P2Alexion Pharmaceuticals, Inc.NCT07037420 ALXN2420 Versus Placebo in Combination With Somatostatin Analogs in Participants With AcromegalyAcromegalyterminated8
2026-06-25P3Astellas Pharma Global Development, Inc.NCT06440967 A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone TherapyHot Flashesactive not recruiting982
2026-06-25P2Kyverna Therapeutics KYTXNCT06588491 KYSA-8: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Treatment Refractory Stiff Person SyndromeStiff-Person Syndrome; SPScompleted27
2026-06-25P2Janssen Research & Development, LLCNCT06785012 A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive DisorderDepressive Disorder, Majorcompleted105
2026-06-25P2Hangzhou PhecdaMed Co., Ltd.NCT07018245 Clinical Trial of TJ0113 Capsules in the Treatment of Patients With Depressive DisorderDepressioncompleted149
2026-06-25P2Sionna Therapeutics Inc. SIONNCT07108153 Proof-of-concept Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of SION-719 When Added to TrikaftaCystic Fibrosis (CF)completed15
2026-06-26P2Hanmi Pharmaceutical Company Limited HAFCNCT04505436 Efocipegtrutide (HM15211) in Adults With Biopsy-Confirmed Nonalcoholic Steatohepatitis (NASH)NASH - Nonalcoholic Steatohepatitiscompleted215
2026-06-26P3AstraZeneca AZNNCT04711252 A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not ReceivER-Positive HER2-Negative Breast Canceractive not recruiting1371
2026-06-26P2ZetrOZ, Inc.NCT06257537 Sustained Acoustic Medicine for Symptomatic Treatment of Knee Pain Related to OsteoarthritisOsteo Arthritis Knee; Arthritiscompleted307
2026-06-26P2Novo Nordisk A/S NVONCT06797869 A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral NeuropathyDiabetes Mellitus, Type 2; Diabetic Peripheral Neuropathycompleted142
2026-06-26P3Sinovac Biotech Co., Ltd SVANCT07211152 Influenza Vaccine (Split Virion), Inactivated, Quadrivalent in Pregnant WomenInfluenzacompleted150
2026-06-28 est.P3EMSNCT05640232 Efficacy and Safety of CDE100 in the Treatment of Menstrual Cramp Pain Associated With Primary DysmenorrheaPrimary Dysmenorrhearecruiting238
2026-06-28 est.P2Gan & Lee Pharmaceuticals.NCT07055386 A Study to Compare the Efficacy and Safety of GZR102 Injection and GZR18 Injection in Type 2 Diabetes MellitusType 2 Diabetes Mellitus (T2DM)active not recruiting90
2026-06-28P3Colgate Palmolive CLNCT07458464 Study to Investigate Toothpaste on Antibacterial Effects in the Different Regions of the MouthPlaque; Gingivitiscompleted95
2026-06-29P3AriBio Co., Ltd.NCT05531526 Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants With Early Alzheimer's Disease (PolariAlzheimer Diseaseactive not recruiting1535
2026-06-29P3Vivacelle BioNCT06072430 A Phase III, Open Label, Randomized, Controlled Study of VBI-S in the Treatment of Hypovolemia in Patients With Septic Shock (VBI-S-02)Septic Shock; Sepsis; Hypovolemiacompleted39
2026-06-29P2Tisento TherapeuticsNCT06402123 A Phase 2b Study of Zagociguat in Patients With MELASMitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS Syndrome)completed43
2026-06-29P3AbbVie ABBVNCT06806293 Study of Oral Atogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual MigraineMenstrual Migraine (MM)active not recruiting468
2026-06-29P3Takeda TAKNCT07047521 A Study on a New Tetravalent Dengue Vaccine (TDV) Formulation in Healthy AdultsDengue Feveractive not recruiting496
2026-06-29P3Novo Nordisk A/S NVONCT07271251 A Research Study to See if Two Different Formulations of Oral Semaglutide Are Equally Safe and Effective in Reducing the Blood Sugar Level in Japanese People WiType 2 Diabetescompleted267
2026-06-30P2Y-mAbs TherapeuticsNCT03363373 Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone MarrowNeuroblastomaactive not recruiting122
2026-06-30 est.P2/P3Zynerba Pharmaceuticals, Inc.NCT03802799 Open Label Extension to Assess the Long-Term Safety and Tolerability of ZYN002 in Children and Adolescents With FXSFragile X Syndromeactive not recruiting476
2026-06-30P2/P3Price Vision GroupNCT03922542 Comparison of Standard vs. Accelerated Corneal CrosslinkingKeratoconus; Ectasia Cornealcompleted508
2026-06-30 est.P1/P2Beijing InnoCare Pharma Tech Co., Ltd.NCT04014205 A Study of Tyrosine Kinase Inhibitor Orelabrutinib (ICP-022) in Patients With r/r B-Cell MalignanciesPart 1:r/r B-cell Malignancies; Part 2:B-cell Malignanciesactive not recruiting81
2026-06-30P1/P2Linnaeus Therapeutics, Inc.NCT04130516 Study Assessing MTD, Safety, Tolerability, PK and Anti-tumor Effects of LNS8801alone and With PembrolizumabSolid Tumor, Adultactive not recruiting200
2026-06-30P2Crinetics Pharmaceuticals Inc.NCT04261712 A Study to Evaluate the Long-Term Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Advance)Acromegalyterminated43
2026-06-30 est.P3United BioPharma UTHRNCT04406727 UB-421 in Combination With Optimized Background Regimen in Patients With Multi-drug Resistant HIV-1 InfectionHIV-1 Infectionunknown50
2026-06-30 est.P2SynAct Pharma ApsNCT04456816 A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Treatment With AP1189 in Patients With iMN and Severe ProteinuriaNephrotic Syndrome Due to Idiopathic Membranous Nephropathy; Severe Proteinuria Due to Idiopathic Merecruiting23
2026-06-30 est.P3PharmaEssentia Japan K.K.NCT04655092 Extension Study of P1101 After Completion of Phase 2 Study in PV Patients or Phase 3 Study in ET PatientsPolycythemia Vera (PV)recruiting67
2026-06-30 est.P2/P3Beacon Therapeutics BBTNCT04850118 A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With XLRPX-Linked Retinitis Pigmentosaactive not recruiting85
2026-06-30 est.P2Longeveron Inc. LGVNNCT04925024 Evaluation of Lomecel-B™ Injection in Patients With Hypoplastic Left Heart Syndrome (HLHS): A Phase IIb Clinical Trial.Hypoplastic Left Heart Syndromeactive not recruiting40
2026-06-30P1/P2Novita Pharmaceuticals, Inc.NCT05023486 NP-G2-044 as Monotherapy and Combination Therapy in Patients With Advanced or Metastatic Solid Tumor MalignanciesAdvanced or Metastatic Solid Tumor Malignanciescompleted121
2026-06-30 est.P1/P2TiumBio Co., Ltd.NCT05204862 Phase 1/2 Study of TU2218 Alone and in Combination With Checkpoint Inhibitors in Patients With Advanced Solid TumorsAdvanced Solid Tumorrecruiting240
2026-06-30 est.P2Curevo IncNCT05304351 Safety and Immunogenicity of CRV-101 Vaccine for the Prevention of Herpes Zoster in Adults Aged 50 Years and OlderHerpes Zoster; Shinglesactive not recruiting1516
2026-06-30 est.P3Shanghai Henlius BiotechNCT05353257 A Study to Evaluate the Efficacy and Safety of Serplulimab in Combination With Chemotherapy and Concurrent Radiotherapy in Patients With Limited-Stage Small CelLimited-Stage Small Cell Lung Canceractive not recruiting511
2026-06-30 est.P1/P2Suzhou Suncadia Biopharmaceuticals Co., Ltd.NCT05416775 Phase Ib/II Study of SHR-8068 Injection in the Treatment of Advanced Non-small Cell Lung CancerAdvanced Non-small Cell Lung Cancerunknown168
2026-06-30 est.P1/P2Suzhou Suncadia Biopharmaceuticals Co., Ltd.NCT05444088 Study of SHR-8068 Combined With Adebrelimab and Bevacizumab in the Treatment of Advanced Hepatocellular CarcinomaAdvanced Hepatocellular Carcinomaunknown129
2026-06-30 est.P3Celcuity Inc CELCNCT05501886 Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (Breast Canceractive not recruiting701
2026-06-30 est.P3Taizhou Hanzhong biomedical co. LTDNCT05652894 A Study of HX008 Compared to Chemotherapy in the First-Line Treatment of Subjects With MSI-H/dMMR Metastatic Colorectal CancerMetastatic Colorectal Canceractive not recruiting190
2026-06-30 est.P3GC Biopharma CorpNCT05686759 A Study to Investigate the Safety and Efficacy of Undiluted Intravenous Infusion of I.V.-Hepabig Inj.Hepatitis Brecruiting105
2026-06-30 est.P3Zenas BioPharma (USA), LLC ZBIONCT05786573 A Study of Obexelimab in Patients With Warm Autoimmune Hemolytic Anemia (SApHiAre)Warm Autoimmune Hemolytic Anemiaactive not recruiting134
2026-06-30 est.P2AstraZeneca AZNNCT05825365 Selumetinib in Chinese Paediatric With Post-operative NF1-PNs, PhaseⅡ, Double-Blinded, Placebo-Controlled StudyNeurofibromatosis Type 1; Plexiform Neurofibromas; Post-operativewithdrawn
2026-06-30 est.P1/P2AkesoNCT05904379 AK112 and AK104 With or Without Chemotherapy in Advanced Non-small Cell Lung CancerAdvanced Non-small-cell Lung Canceractive not recruiting233
2026-06-30P3Tenax Therapeutics, Inc. TENXNCT05983250 LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEFPulmonary Hypertensionactive not recruiting230
2026-06-30P2AstraZeneca AZNNCT06040099 A US Study to Evaluate Transarterial Radioembolization (TARE) in Combination With Durvalumab and Bevacizumab Therapy in People With Unresectable Hepatocellular Hepatocellular Carcinoma (HCC)active not recruiting58
2026-06-30 est.P1/P2GlaxoSmithKlineNCT06077877 A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Anticancer Activity of GSK4524101 Alone or With Niraparib in ParticipantNeoplasmsactive not recruiting42
2026-06-30P2Hillhurst Biopharmaceuticals, Inc.NCT06144749 A Safety, Efficacy, and Pharmacokinetic (PK) Study of HBI-002, an Oral Carbon Monoxide (CO) Therapeutic, in Subjects With Sickle Cell Disease (SCD)Anemia, Sickle Cellcompleted13
2026-06-30 est.P1/P2LaNova Medicines LimitedNCT06187402 A Study of LM-24C5 For Advanced Solid TumorsAdvanced Solid Tumorrecruiting49
2026-06-30 est.P3Beijing Union Pharmaceutical Factory LtdNCT06243614 Phase Ⅲ Clinical Trial of Buagafuran Capsules in the Treatment of GADGeneralized Anxiety Disorderrecruiting410
2026-06-30 est.P3Beijing Union Pharmaceutical Factory LtdNCT06243640 Phase 3 Clinical Trial of Buagafuran Capsules in the Treatment of GADGeneralized Anxiety Disorderrecruiting504
2026-06-30 est.P2Keymed Biosciences Co.LtdNCT06372678 Study of CM326 in Participants With Chronic Rhinosinusitis With Nasal PolyposisChronic Rhinosinusitis With Nasal Polypsunknown90
2026-06-30P2Ryvu Therapeutics SANCT06397313 RVU120 in Patients With Intermediate or High-risk, Primary or Secondary MyelofibrosisMyelofibrosisterminated36
2026-06-30 est.P2LKGS_277NCT06410859 Botulinum Toxin Type A for Injection (HengLi®) in the Treatment of Trigeminal NeuralgiaTrigeminal Neuralgiaunknown240
2026-06-30 est.P2/P3Tego Science, Inc.NCT06414005 A Phase 2b/3 Study of TPX-115 on Partial-thickness Rotator Cuff TearPartial Thickness Rotator Cuff Tearrecruiting166
2026-06-30 est.P2Qilu Pharmaceutical Co., Ltd.NCT06446388 Study of QLS31905 and/or QL1706 Combination With Chemotherapy in the Advanced Malignant Solid TumorsAdvanced Solid Tumornot yet recruiting360
2026-06-30 est.P2Shenzhen TargetRx Co., Ltd.NCT06453902 TGRX-678 Chinese Phase II in Chronic Myelogenous Leukemia (CML) PatientsChronic Myeloid Leukemia; Accelerated Phase CMLrecruiting40
2026-06-30P3GlaxoSmithKlineNCT06472076 A Study of Belrestotug Plus Dostarlimab Compared With Placebo Plus Pembrolizumab in Previously Untreated Participants With Programmed Death Ligand 1 (PD-L1) HigLung Cancer, Non-Small Cellactive not recruiting88
2026-06-30 est.P2Chengdu Zenitar Biomedical Technology Co., LtdNCT06485219 A Phase IIa Clinical Study of Purinostat Mesylate for Injection in Patients With Peripheral T-Cell Lymphoma and Cutaneous T-Cell LymphomaRelapsed or Refractory Peripheral T-cell Lymphoma (PTCL); Cutaneous T-cell Lymphoma (CTCL)active not recruiting50
2026-06-30 est.P2Shanghai Argo Biopharmaceutical Co., Ltd.NCT06497127 A Study in Patients With Mixed DyslipidemiaMixed Dyslipidemiaactive not recruiting145
2026-06-30 est.P3Apnimed APMDNCT06566820 Continuation Protocol for Obstructive Sleep Apnea (OSA)OSAenrolling by invitation1280
2026-06-30 est.P1/P2Suzhou Puhe Pharmaceutical Technology Co., LTDNCT06590194 PH009-1 in Patients With EGFR Mutation Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)unknown96
2026-06-30 est.P3Kexing Biopharm Co., Ltd.NCT06711523 Study Evaluating PEG-G-CSF Injectionin Preventing Neutropenia After ChemotherapyNeutropenia, Chemotherapy-Induced Febrile; Breast Neoplasm Femaleactive not recruiting250
2026-06-30 est.P2NOBO MedicineNCT06737250 NB02 (Poseltinib) Combined Rituximab and Lenalidomide in R/R PCNSLPrimary CNS Lymphoma (PCNSL)recruiting33
2026-06-30 est.P3Telix Pharmaceuticals (Innovations) Pty Limited TLXNCT06750419 89Zr-TLX250 for PET/CT Imaging of ccRCC - ZIRCON-CP StudyClear Cell Renal Cell Carcinomarecruiting82
2026-06-30 est.P1/P2Multitude Therapeutics Inc.NCT06782334 AMT-116 in Patients with Solid TumorsAdvanced Solid Tumorsrecruiting144
2026-06-30 est.P2Shanghai Argo Biopharmaceutical Co., Ltd.NCT06846398 A Phase 2 in Adult Subjects With Hereditary AngioedemaHereditary Angioedema (HAE)active not recruiting25
2026-06-30 est.P1/P2Shanghai Institute Of Biological ProductsNCT06932523 A Study to Evaluate the Safety of Recombinant Herpes Zoster Vaccine for Healthy IndividualsHerpes Zoster (HZ)recruiting645
2026-06-30 est.P1/P2Innovent Biologics (Suzhou) Co. Ltd.NCT06974812 IBI3014 in Participants With Unresectable Locally Advanced or Metastatic Solid TumorsUnresectable Locally Advanced or Metastatic Solid Tumorsrecruiting250
2026-06-30 est.P2Keymed Biosciences Co.LtdNCT07039578 Study Evaluating the Efficacy and Safety of CM336 Injection in the Treatment of Light-Chain AmyloidosisPrimary Light-Chain Amyloidosisrecruiting90
2026-06-30 est.P3Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. SBFMNCT07042126 Evaluation of 611 in Chinese Adolescents With Moderate to Severe Atopic DermatitisDermatitis, Atopicrecruiting180
2026-06-30 est.P2Sirius Therapeutics Co., Ltd. SIRINCT07140523 A Study to Compare the Efficacy and Safety of SRSD107 and Enoxaparin in Adult Subjects Undergoing TKAVenous Thromboembolismrecruiting450
2026-06-30 est.P3Prime Gene Therapeutics Co., Ltd.NCT07146126 A Phase III Study to Assess the Efficacy and Safety of PG-011 Nasal Spray in Adults With Moderate to Severe Seasonal Allergic RhinitisSeasonal Allergic Rhinitis; SARnot yet recruiting600
2026-06-30 est.P3Onconic Therapeutics Inc.NCT07160790 Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 in Patients With Non-erosive Gastroesophageal Reflux DiseaseNon-erosive Gastroesophageal Reflux Diseasenot yet recruiting321
2026-06-30 est.P3Laboratorios Sophia S.A de C.V.NCT07305987 PRO-232 in Patients Subjected to Cataract SurgeryCataract Extractionrecruiting134
2026-06-30 est.P1/P2PT. Prodia Stem Cell IndonesiaNCT07429253 Secretome vs. PRP Injections for Hair Density and Growth in Androgenetic Alopecia PatientsAndrogenetic Alopeciarecruiting40
2026-06-30 est.P2Clarent Biopharma, Inc.NCT07687966 CBP-0276 to Reduce Opioid Use in Adults Undergoing Major Orthopedic SurgeryHip or Knee Replacementrecruiting80

← 2026-05 | 2026-07 →

Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA (openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score. Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP readout_calendar / fda_decisions. Not investment advice.